Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 211

Results For "test"

2326 News Found

U.S. FDA accepts Bristol Myers Squibb’s application for Deucravacitinib
Biotech | November 30, 2021

U.S. FDA accepts Bristol Myers Squibb’s application for Deucravacitinib

Applications supported by positive results from the pivotal Phase 3 POETYK-PSO clinical trial program demonstrating superior efficacy of deucravacitinib over Otezla (apremilast)


RDIF believes that Sputnik vaccines can neutralise Omicron
News | November 30, 2021

RDIF believes that Sputnik vaccines can neutralise Omicron

According to the Russian Direct Investment Fund (RDIF), the Russian Sputnik V and Sputnik Light vaccines have proven to be highly effective against all variants of SARC-Cov-2


UAE authorises Sputnik Light vaccine as universal booster
News | November 30, 2021

UAE authorises Sputnik Light vaccine as universal booster

Booster dose is available to all residents aged 18+ and can be applied six months after the second dose of any other vaccine administered in UAE


AMPATH launches its pathology laboratory in Mumbai
Clinical Trials | November 29, 2021

AMPATH launches its pathology laboratory in Mumbai

The company has has 10 existing labs in India


Thermo Fisher Scientific confirms its TaqParth Covid-19 kit can detect Omicron
Medical Device | November 29, 2021

Thermo Fisher Scientific confirms its TaqParth Covid-19 kit can detect Omicron

The Omicron variant, which was designated a variant of concern by the World Health Organization (WHO), has more than 30 mutations in the spike protein alone


ZenOnco.io raises US $ 1.4 mn in seed funding
Startup | November 29, 2021

ZenOnco.io raises US $ 1.4 mn in seed funding

The funds will be used to scale up existing operations and launch new products


Fujifilm launches awareness campaign on detecting TB
Public Health | November 28, 2021

Fujifilm launches awareness campaign on detecting TB

The campaign aims to increase awareness about Tuberculosis as a curable disease and promote early diagnosis.


Network18 Group and Novartis India launch ‘Netra Suraksha’ to raise awareness around diabetic eye diseases
Events | November 27, 2021

Network18 Group and Novartis India launch ‘Netra Suraksha’ to raise awareness around diabetic eye diseases

The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly


Pharma firms switch to advanced pharma manufacturing
Supply Chain | November 27, 2021

Pharma firms switch to advanced pharma manufacturing

Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies


Indian Pharmaceutical Market reports slower growth in October
News | November 26, 2021

Indian Pharmaceutical Market reports slower growth in October

Contribution from the top five therapies stood at 58% of IPM in October 2021. These therapies are cardiac, anti-infectives, gastro-intestinal, anti-diabetic and vitamins